期刊文献+

虎杖苷单体对急性病毒性心肌炎的影响 被引量:3

Effect of polydatin monomer on acute viral myocarditis
下载PDF
导出
摘要 目的探讨虎杖苷(PD)对柯萨奇病毒B3(CVB3)感染小鼠心肌微血管密度(MVD)的影响及对心肌的保护作用。方法120只Balb/c雄性小鼠随机分为4组:正常对照组、CVB3感染组、CVB3感染加PD治疗组和PD对照组,分别在实验的第3、7、10、14、21、30天处死动物,留取血清和心肌标本,PFU法测定心肌组织内感染性病毒颗粒,免疫组化检测心肌CD34表达,显微镜下计数心肌组织MVD。结果与正常对照组比较,感染组小鼠MVD计数增加(P<0.05);与感染组比较,PD治疗组小鼠心肌组织内病毒滴度明显低于感染组(P<0.05);MVD计数显著增高,死亡率显著降低(P<0.05)。结论PD可以明显减轻病毒性心肌炎时心肌病理损害,其保护作用可能与抗CVB3病毒和使心肌MVD增高有关。 Objective To investigate the regulation effect of PD on the MVD of myocardia1 tissue and the effect of PD on viral myocarditis in vivo.Methods One hundred and twenty male Balb/c mice were randomly divided into four groups:normal control group,the Coxsackie virus B3(CVB3) infected group,the CVB3 infected and PD treated group,PD control group.They were killed on days 3,7,10,14,21and 30 respectively.Serum and cardiac muscle were preserved.Virus titer in heart by plaqe-forming assay.The CD34 immunohistochemical studies and medical imagine analysis were performed.Results Markedly increased microvessel density were observed in the myocardial tissue of infected mice in comparison with contro1 group(P〈0.05).Virus titer in group of CVB3 infected mice was significantly higher than that in group of infected mice with PD treatment.Markedly increased microvessel density were observed in PD-treated group in comparison with CVB3 infected group(P〈0.05),mortality was greatly reduced.Conclusion PD therapy improved the severity of myocardial lesions in viral myocarditis.The therapeutic effect of PD might be mediated through resisting CVB3 and markedly increased microvessel density.
出处 《滨州医学院学报》 2008年第2期95-98,共4页 Journal of Binzhou Medical University
关键词 虎杖苷 柯萨奇B3病毒 病毒性心肌炎 MVD polydatin,CVB3,viral myocarditis,microvessel density
  • 相关文献

参考文献8

  • 1王卫华,肖红,陈科力,杨占秋,余言松,陈晓湘,文莉.虎杖提取液抗柯萨奇病毒B3的实验研究[J].湖北中医杂志,2001,23(9):47-48. 被引量:25
  • 2Yu R, Hebbar V, Kim DW, et al. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways [ J]. Mol Phannacol,2001, 60( 1 ) :217-224.
  • 3Liu P, Mason JW. Advances in the understanding of myocarditis. Circulation,2001,104 (9) : 1076-1082.
  • 4Panchal VR, Rehman J, Nguyen AT, et al. Reduced pericardial levels of endostatin correlate with collateral development in patients with is- chemic heart disease[ J ]. 2004,43 ( 8 ) : 1383-1387.
  • 5Tomanek RT, Zheng W. Role of growth factors in coronary morphogenesis[J]. Tex Heart Inst J, 2002, 29(4): 250-254.
  • 6Ehrbar M , Metters A, Zammaretti P,et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity [J ]. J Control Release,2005 , 101 ( 1-3 ) :93-109.
  • 7Jingjing L, Srinivasan B, Bian X, et al. Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart[ J]. Mol Cell Biochem,2000,214(1-2) :23-30.
  • 8Harvey BG,Maroni J,O'Donoghue KA,et al. Safety of local delivery of low- and intermedlate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions [ J ]. Hum Gene Ther,2002 , 13 ( 1 ) : 15453.

二级参考文献2

共引文献24

同被引文献57

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部